Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Disease Progression and ERCC2[original query] |
---|
No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis. Lung cancer (Amsterdam, Netherlands) 2011 Jun 72 (3): 370-7. Yin Ming, Yan Jingrong, Voutsina Alexandra, Tibaldi Carmelo, Christiani David C, Heist Rebecca S, Rosell Rafael, Booton Richard, Wei Qing |
Genetic variants in DNA repair predicts the survival of patients with esophageal cancer. Annals of surgery 2011 May 253 (5): 918-27. Lee Jang-Ming, Yang Pei-Wen, Yang Shi-Yi, Chuang Tzu-Hsuen, Tung En-Chi, Chen Jin-Shing, Huang Pei-Ming, Lee Yung-Ch |
ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Mar 17 (6): 1632-40. Yin Ming, Yan Jingrong, Martinez-Balibrea Eva, Graziano Francesco, Lenz Heinz-Josef, Kim Hyo-Jin, Robert Jacques, Im Seock-Ah, Wang Wei-Shu, Etienne-Grimaldi Marie-Christine, Wei Qing |
Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy. Cancer chemotherapy and pharmacology 2021 Jul . Duran Goretti, Cruz Raquel, Aguín Santiago, Barros Francisco, Giráldez José María, Bernárdez Beatriz, Zarra Irene, López-López Rafael, Carracedo Ángel, Lamas María Jes |
- Page last reviewed:Feb 1, 2024
- Content source: